Goldman Sachs Group »

Ishares Tr genomics immun shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $209k 7.2k 29.05
2023-06-30 $274k 12k 23.35
2023-03-31 $273k 12k 23.27
2022-12-31 $540k 21k 25.17
2022-06-30 $1.4M 50k 28.89
2022-03-31 $404k 12k 34.44
2021-12-31 $514k 12k 43.82